Bullboard - Stock Discussion Forum Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the... see more

Add To Watchlist

TSX:RVX - Post Discussion

Resverlogix Corp > Apabetalone’s Beneficial Effects on COVID-19 Published in ..

View:

Post by seanj1 on Mar 18, 2021 9:09pm

Apabetalone’s Beneficial Effects on COVID-19 Published in ..

Well by the time this gets to the final hurdle, Covid 19 will be a thing of the past as far as pandemic goes, eventhough it will be around for a while like a flu. Also the current management team is not capable to get it done. Apabetalone's potential in treating other similar disease will be the potential success of the company but we will not get there with the current management team. McCaffrey is getting paid his annual hefty salary no matter what, so he likes his cozy job and BOD...

https://ca.wallmine.com/tsx/rvx/officer/2073968/donald-mccaffrey

What is the salary of Donald McCaffrey?

As the Chairman of the Board, President, Chief Executive Officer, and Secretary of Resverlogix, the total compensation of Donald McCaffrey at Resverlogix is CAD$1,954,160. There are no executives at Resverlogix getting paid more.

323